To determine the mechanism of impaired insulin-stimulated muscle glycogen metabolism in patients with poorly controlled insulin-dependent diabetes mellitus (IDDM), we used 13C-NMR spectroscopy to monitor the peak intensity of the C1 resonance of the glucosyl units in muscle glycogen during a 6-h hyperglycemic-hyperinsulinemic clamp using [1-(13)C]glucose-enriched infusate followed by nonenriched glucose. Under similar steady state (t = 3-6 h) plasma glucose (approximately 9.0 mM) and insulin concentrations (approximately 400 pM), nonoxidative glucose metabolism was significantly less in the IDDM subjects compared with age-weight-matched control subjects (37+/-6 vs. 73+/-11 micromol/kg of body wt per minute, P < 0.05), which could be attributed to an approximately 45% reduction in the net rate of muscle glycogen synthesis in the IDDM subjects compared with the control subjects (108+/-16 vs. 195+/-6 micromol/liter of muscle per minute, P < 0.001). Muscle glycogen turnover in the IDDM subjects was significantly less than that of the controls (16+/-4 vs. 33+/-5%, P < 0.05), indicating that a marked reduction in flux through glycogen synthase was responsible for the reduced rate of net glycogen synthesis in the IDDM subjects. 31P-NMR spectroscopy was used to determine the intramuscular concentration of glucose-6-phosphate (G-6-P) under the same hyperglycemic-hyperinsulinemic conditions. Basal G-6-P concentration was similar between the two groups (approximately 0.10 mmol/kg of muscle) but the increment in G-6-P concentration in response to the glucose-insulin infusion was approximately 50% less in the IDDM subjects compared with the control subjects (0.07+/-0.02 vs. 0.13+/-0.02 mmol/kg of muscle, P < 0.05). When nonoxidative glucose metabolic rates in the control subjects were matched to the IDDM subjects, the increment in the G-6-P concentration (0.06+/-0.02 mmol/kg of muscle) was no different than that in the IDDM subjects. Together, these data indicate that defective glucose transport/phosphorylation is the major factor responsible for the lower rate of muscle glycogen synthesis in the poorly controlled insulin-dependent diabetic subjects.
G W Cline, I Magnusson, D L Rothman, K F Petersen, D Laurent, G I Shulman
Title and authors | Publication | Year |
---|---|---|
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD |
Endocrine Reviews | 2025 |
Mechanisms of insulin resistance in type 1 diabetes mellitus: A case of glucolipotoxicity in skeletal muscle
Sammut MJ, Dotzert MS, Melling CW |
Journal of Cellular Physiology | 2024 |
Quantifying beta cell function in the preclinical stages of type 1 diabetes.
Galderisi A, Carr ALJ, Martino M, Taylor P, Senior P, Dayan C |
Diabetologia | 2023 |
Avocatin B Protects Against Lipotoxicity and Improves Insulin Sensitivity in Diet‐Induced Obesity
N Ahmed, M Tcheng, A Roma, M Buraczynski, P Jayanth, K Rea, TA Akhtar, PA Spagnuolo |
Molecular Nutrition & Food Research | 2019 |
Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes
J Shen, B Zhu |
Molecular medicine reports | 2018 |
Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes
MV Svart, N Rittig, U Kampmann, TS Voss, N Møller, N Jessen |
Diabetologia | 2017 |
Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes: PORKSEN et al
N Porksen, H Linnebjerg, P Garhyan, EC Lam, MP Knadler, SJ Jacober, U Hoevelmann, L Plum-Moerschel, E Watkins, A Gastaldelli, T Heise |
Diabetes, obesity & metabolism | 2017 |
Methodological and physiological test-retest reliability of 13 C-MRS glycogen measurements in liver and in skeletal muscle of patients with type 1 diabetes and matched healthy controls: Test-Retest Reliability of Liver and Muscle Glycogen Determination
T Buehler, L Bally, AS Dokumaci, C Stettler, C Boesch |
NMR in Biomedicine | 2016 |
The Interplay of Autoimmunity and Insulin Resistance in Type 1 Diabetes
Natalie J. Nokoff, Marian Rewers, Melanie Cree Green |
Discovery medicine | 2016 |
BRIEF REPORT: Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls
L Bally, T Buehler, AS Dokumaci, C Boesch, C Stettler |
Diabetes Research and Clinical Practice | 2015 |
Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes
T Jelenik, G Séquaris, K Kaul, DM Ouwens, E Phielix, J Kotzka, B Knebel, J Weiß, AL Reinbeck, L Janke, P Nowotny, HJ Partke, D Zhang, GI Shulman, J Szendroedi, M Roden |
Diabetes | 2014 |
A Fermented Soy Permeate Improves the Skeletal Muscle Glucose Level Without Restoring the Glycogen Content in Streptozotocin-Induced Diabetic Rats
L Malardé, S Vincent, L Lefeuvre-Orfila, T Efstathiou, C Groussard, A Gratas-Delamarche |
Journal of Medicinal Food | 2013 |
The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes
BC Bergman, D Howard, IE Schauer, DM Maahs, JK Snell-Bergeon, TW Clement, RH Eckel, L Perreault, M Rewers |
The Journal of clinical endocrinology and metabolism | 2012 |
Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes
BC Bergman, D Howard, IE Schauer, DM Maahs, JK Snell-Bergeon, RH Eckel, L Perreault, M Rewers |
The Journal of clinical endocrinology and metabolism | 2012 |
Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery
CH Anderwald, A Tura, M Promintzer-Schifferl, G Prager, M Stadler, B Ludvik, H Esterbauer, MG Bischof, A Luger, G Pacini, M Krebs |
Diabetes care | 2012 |
The interplay of autoimmunity and insulin resistance in type 1 diabetes
Natalie J Nokoff, Marian Rewers, Melanie Cree Green |
Discovery medicine | 2012 |
Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes
M Kacerovsky, A Brehm, M Chmelik, AI Schmid, J Szendroedi, G Kacerovsky-Bielesz, P Nowotny, A Lettner, M Wolzt, JG Jones, M Roden |
Journal of Internal Medicine | 2011 |
Metabolic Remodeling of Human Skeletal Myocytes by Cocultured Adipocytes Depends on the Lipolytic State of the System
JP Kovalik, D Slentz, RD Stevens, WE Kraus, JA Houmard, JB Nicoll, YR Lea-Currie, K Everingham, CL Kien, BM Buehrer, DM Muoio |
Diabetes | 2011 |
Effects of Gastric Bypass Surgery on Insulin Resistance and Insulin Secretion in Nondiabetic Obese Patients
M Promintzer-Schifferl, G Prager, C Anderwald, M Mandl, H Esterbauer, S Shakeri-Leidenmühler, G Pacini, M Stadler, MG Bischof, B Ludvik, A Luger, M Krebs |
Obesity | 2011 |
Dietary antioxidant interventions in type 2 diabetes patients: a meta-analysis
S Akbar, S Bellary, HR Griffiths |
The British Journal of Diabetes & Vascular Disease | 2011 |
Textbook of Diabetes
PM Jones, SJ Persaud |
Textbook of Diabetes | 2010 |
mTOR function in skeletal muscle: a focal point for overnutrition and exercise
DA Rivas, SJ Lessard, VG Coffey |
Applied Physiology, Nutrition, and Metabolism | 2009 |
Metabolomics-based methods for early disease diagnostics
GA Gowda, S Zhang, H Gu, V Asiago, N Shanaiah, D Raftery |
Expert Review of Molecular Diagnostics | 2008 |
Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance
TR Koves, JR Ussher, RC Noland, D Slentz, M Mosedale, O Ilkayeva, J Bain, R Stevens, JR Dyck, CB Newgard, GD Lopaschuk, DM Muoio |
Cell Metabolism | 2008 |
Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation
AJ Hoy, CR Bruce, A Cederberg, N Turner, DE James, GJ Cooney, EW Kraegen |
American journal of physiology. Endocrinology and metabolism | 2007 |
Role of proton MR for the study of muscle lipid metabolism
C Boesch, J Machann, P Vermathen, F Schick |
NMR in Biomedicine | 2006 |
In Vivo MR Techniques in Drug Discovery and Development
B Jucker, D Laurent |
In Vivo MR Techniques in Drug Discovery and Development | 2006 |
Cerebral pyruvate carboxylase flux is unaltered during bicuculline-seizures
AB Patel, GM Chowdhury, RA de Graaf, DL Rothman, RG Shulman, KL Behar |
Journal of Neuroscience Research | 2004 |
In Situ Evidence That Peripheral Insulin Resistance in Adolescents with Poorly Controlled Type 1 Diabetes Is Associated with Impaired Suppression of Lipolysis: A Microdialysis Study
RA Heptulla, A Stewart, S Enocksson, F Rife, TY Ma, RS Sherwin, WV Tamborlane, S Caprio |
Pediatric Research | 2003 |
Effects of Obesity on Substrate Utilization during Exercise
BH Goodpaster, RR Wolfe, DE Kelley |
Obesity | 2002 |
In vivo13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2-13C]glucose infusion
NR Sibson, GF Mason, J Shen, GW Cline, AZ Herskovits, JE Wall, KL Behar, DL Rothman, RG Shulman |
Journal of Neurochemistry | 2001 |
NMR Spectroscopy in β Cell Engineering and Islet Transplantation
KK Papas, CK Colton, JS Gounarides, ES Roos, MA Jarema, MJ Shapiro, LL Cheng, GW Cline, GI Shulman, H Wu, S Bonner-Weir, GC Weir |
Annals of the New York Academy of Sciences | 2001 |
Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA-transaminase inhibition
AB Patel, DL Rothman, GW Cline, KL Behar |
Brain Research | 2001 |
Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps
LM Perriott, T Kono, RR Whitesell, SM Knobel, DW Piston, DK Granner, AC Powers, JM May |
American journal of physiology. Endocrinology and metabolism | 2001 |
Targeted Molecular Imaging in Oncology
EE Kim, DJ Yang |
2001 | |
Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity
A Dresner, D Laurent, M Marcucci, ME Griffin, S Dufour, GW Cline, LA Slezak, DK Andersen, RS Hundal, DL Rothman, KF Petersen, GI Shulman |
Journal of Clinical Investigation | 1999 |
APPLICATIONS OF NMR SPECTROSCOPY TO STUDY MUSCLE GLYCOGEN METABOLISM IN MAN
MR MD, GI PhD |
Annual Review of Medicine | 1999 |
In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives
M Rudin, N Beckmann, R Porszasz, T Reese, D Bochelen, A Sauter |
NMR in Biomedicine | 1999 |
A novel 13 C NMR method to assess intracellular glucose concentration in muscle, in vivo
GW Cline, BM Jucker, Z Trajanoski, AJ Rennings, GI Shulman |
American journal of physiology. Endocrinology and metabolism | 1998 |
Insulin Resistance
A Voll, J Kloster |
Acta Medica Scandinavica | 1957 |